SCAMP1

Summary

SCAMP1 (secretory carrier membrane protein 1, HGNC:10563) is a protein-coding gene on chromosome 5q14.1, encoding Secretory carrier-associated membrane protein 1 (O15126). Functions in post-Golgi recycling pathways.

This gene product belongs to the SCAMP family of proteins, which are secretory carrier membrane proteins. They function as carriers to the cell surface in post-golgi recycling pathways. Different family members are highly related products of distinct genes, and are usually expressed together. These findings suggest that these protein family members may function at the same site during vesicular transport rather than in separate pathways. A pseudogene of this gene has been defined on chromosome 1. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 9522 — RefSeq curated summary.

At a glance

• GWAS associations: 5
• Clinical variants (ClinVar): 25 total
• MANE Select transcript: NM_004866

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:10563
Approved symbol	SCAMP1
Name	secretory carrier membrane protein 1
Location	5q14.1
Locus type	gene with protein product
Status	Approved
Aliases	SCAMP37
Ensembl gene	ENSG00000085365
Ensembl biotype	protein_coding
OMIM	606911
Entrez	9522

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 9 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000320280, ENST00000506858, ENST00000510030, ENST00000511551, ENST00000614488, ENST00000618166, ENST00000621999, ENST00000878187, ENST00000878188, ENST00000920041, ENST00000962697

RefSeq mRNA: 2 — MANE Select: NM_004866 NM_001290229, NM_004866

CCDS: CCDS75264, CCDS78025

Canonical transcript exons

ENST00000621999 — 9 exons

Exon	Start	End
ENSE00003467010	78421801	78421960
ENSE00003478091	78418775	78418903
ENSE00003716665	78449933	78450034
ENSE00003724251	78415520	78415618
ENSE00003729644	78475504	78480739
ENSE00003732635	78360617	78360728
ENSE00003738003	78416541	78416649
ENSE00003742063	78388837	78388914
ENSE00003750655	78459245	78459362

Expression profiles

Bgee: expression breadth ubiquitous, 295 present calls, max score 98.61.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 43.2448 / max 385.2918, expressed in 1811 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter ID	TPM avg	Samples expressed
57204	24.6880	1792
57200	5.6737	1618
57203	4.9674	1635
57205	4.1752	1505
57201	1.8665	1100
57202	1.4777	948
57198	0.3090	141
57199	0.0873	16

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
pigmented layer of retina	UBERON:0001782	98.61	gold quality
choroid plexus epithelium	UBERON:0003911	98.38	gold quality
cortical plate	UBERON:0005343	98.29	gold quality
lateral nuclear group of thalamus	UBERON:0002736	97.93	gold quality
superior vestibular nucleus	UBERON:0007227	97.86	gold quality
Brodmann (1909) area 23	UBERON:0013554	97.32	gold quality
islet of Langerhans	UBERON:0000006	97.24	gold quality
secondary oocyte	CL:0000655	97.23	gold quality
buccal mucosa cell	CL:0002336	97.21	gold quality
cartilage tissue	UBERON:0002418	97.08	gold quality
medulla oblongata	UBERON:0001896	96.92	gold quality
seminal vesicle	UBERON:0000998	96.86	gold quality
Brodmann (1909) area 46	UBERON:0006483	96.81	gold quality
parietal lobe	UBERON:0001872	96.62	gold quality
middle temporal gyrus	UBERON:0002771	96.50	gold quality
endothelial cell	CL:0000115	96.49	gold quality
postcentral gyrus	UBERON:0002581	96.46	gold quality
trigeminal ganglion	UBERON:0001675	96.40	gold quality
ventral tegmental area	UBERON:0002691	96.40	gold quality
superior frontal gyrus	UBERON:0002661	96.37	gold quality
pons	UBERON:0000988	96.33	gold quality
entorhinal cortex	UBERON:0002728	96.13	gold quality
parotid gland	UBERON:0001831	96.06	gold quality
caput epididymis	UBERON:0004358	95.98	gold quality
mammalian vulva	UBERON:0000997	95.96	gold quality
CA1 field of hippocampus	UBERON:0003881	95.95	gold quality
dorsal plus ventral thalamus	UBERON:0001897	95.83	gold quality
penis	UBERON:0000989	95.82	gold quality
oocyte	CL:0000023	95.80	gold quality
mucosa of paranasal sinus	UBERON:0005030	95.80	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	no	0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

248 targeting SCAMP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-4668-3P	100.00	68.74	2635
HSA-LET-7A-3P	100.00	74.03	3932
HSA-LET-7B-3P	100.00	74.08	3913
HSA-LET-7F-1-3P	100.00	74.02	3928
HSA-MIR-98-3P	100.00	74.08	3907
HSA-MIR-1277-5P	100.00	73.95	5056
HSA-MIR-200B-3P	100.00	73.31	2693
HSA-MIR-200C-3P	100.00	73.35	2685
HSA-MIR-429	100.00	73.44	2698
HSA-MIR-3163	100.00	77.23	8605
HSA-MIR-3120-5P	100.00	65.56	965
HSA-MIR-3064-3P	100.00	70.09	1254
HSA-MIR-5692A	100.00	74.40	6850
HSA-MIR-8485	100.00	77.57	4731
HSA-MIR-656-3P	100.00	72.15	2788
HSA-MIR-3613-3P	100.00	76.36	7965
HSA-MIR-4776-3P	100.00	68.73	1340
HSA-MIR-548C-3P	99.99	74.01	7587
HSA-MIR-4531	99.99	69.70	3181
HSA-MIR-371B-5P	99.99	75.34	4759
HSA-MIR-4789-3P	99.99	70.75	2484
HSA-MIR-4789-5P	99.98	70.76	2721
HSA-MIR-12136	99.98	72.81	5713
HSA-MIR-373-5P	99.98	75.36	4753
HSA-MIR-616-5P	99.98	75.58	4775
HSA-MIR-4482-3P	99.98	72.50	3147
HSA-MIR-548N	99.98	71.94	4170
HSA-MIR-4803	99.98	71.99	3117
HSA-MIR-27A-3P	99.98	72.13	2955
HSA-MIR-27B-3P	99.98	72.13	2955

Literature-anchored findings (GeneRIF, showing 5)

• RNA interference-mediated downregulation of SCAMP1 resulted in a marked reduction in cell migration and invasion, but not proliferation in tumor cell lines. (PMID:23653380)
• SCAMP1 enhances Mtss1 anti-invasive function in HER2+/ER-/PR- breast cancer, by promoting its protein trafficking leading to elevated levels of RAC1-GTP and increased cell-cell adhesions. (PMID:29497041)
• Prognostic role of SCAMP family in acute myeloid leukemia. (PMID:31988488)
• Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer (PMID:32401536)
• Multiomics Analysis of Endocytosis upon HBV Infection and Identification of SCAMP1 as a Novel Host Restriction Factor against HBV Replication. (PMID:35216324)

Cross-species orthologs

5 orthologs

Organism	Symbol	Gene ID
danio_rerio	scamp1	ENSDARG00000036911
mus_musculus	Scamp1	ENSMUSG00000021687
rattus_norvegicus	Scamp1	ENSRNOG00000061582
drosophila_melanogaster	Scamp	FBGN0040285
caenorhabditis_elegans	scm-1	WBGENE00004743

Paralogs (4): SCAMP3 (ENSG00000116521), SCAMP2 (ENSG00000140497), SCAMP5 (ENSG00000198794), SCAMP4 (ENSG00000227500)

Protein

Protein identifiers

Secretory carrier-associated membrane protein 1 — O15126 (reviewed: O15126)

All UniProt accessions (5): O15126, A0A087WTX8, A0A087WU14, A0A087WXB0, A0A087WZA6

UniProt curated annotations — full annotation on UniProt →

Function. Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface.

Subunit / interactions. Interacts with SYNRG and ITSN1. Interacts with SLC9A7.

Subcellular location. Golgi apparatus. trans-Golgi network membrane. Recycling endosome membrane.

Tissue specificity. Widely expressed, with highest expression in brain.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the SCAMP family.

Isoforms (2)

UniProt ID	Names	Canonical?
O15126-1	1	yes
O15126-2	2

RefSeq proteins (2): NP_001277158, NP_004857* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR007273	SCAMP	Family

Pfam: PF04144

UniProt features (19 total): topological domain 5, transmembrane region 4, modified residue 3, sequence conflict 3, initiator methionine 1, chain 1, region of interest 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-O15126-F1	79.31	0.43

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 2, 2, 45

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

ID	Pathway
R-HSA-6798695	Neutrophil degranulation
R-HSA-168249	Innate Immune System
R-HSA-168256	Immune System

MSigDB gene sets: 334 (showing top): BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP, FREAC2_01, REACTOME_INNATE_IMMUNE_SYSTEM, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, MORF_MSH3, GOCC_SECRETORY_GRANULE, MORF_BRCA1, MORF_ATRX, MITSIADES_RESPONSE_TO_APLIDIN_DN, GOBP_VESICLE_MEDIATED_TRANSPORT, MORF_ESR1, NFKB_Q6, GOBP_EXOCYTOSIS

GO Biological Process (5): exocytosis (GO:0006887), post-Golgi vesicle-mediated transport (GO:0006892), endocytosis (GO:0006897), protein transport (GO:0015031), establishment of localization in cell (GO:0051649)

GO Molecular Function (2): protein domain specific binding (GO:0019904), protein binding (GO:0005515)

GO Cellular Component (13): trans-Golgi network (GO:0005802), plasma membrane (GO:0005886), membrane (GO:0016020), clathrin-coated vesicle (GO:0030136), synaptic vesicle membrane (GO:0030672), trans-Golgi network membrane (GO:0032588), specific granule membrane (GO:0035579), zymogen granule membrane (GO:0042589), recycling endosome membrane (GO:0055038), endosome (GO:0005768), Golgi apparatus (GO:0005794), cytoplasmic vesicle membrane (GO:0030659), synapse (GO:0045202)

Reactome top-level categories

Rollup of top-2 pathways:

Category	Pathways
Innate Immune System	1
Immune System	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
vesicle-mediated transport	2
secretory granule membrane	2
endomembrane system	2
cytoplasmic vesicle	2
secretion by cell	1
vesicle fusion to plasma membrane	1
Golgi vesicle transport	1
vesicle budding from membrane	1
membrane invagination	1
import into cell	1
transport	1
intracellular protein localization	1
establishment of protein localization	1
establishment of localization	1
cellular localization	1
protein binding	1
binding	1
Golgi apparatus subcompartment	1
membrane	1
cell periphery	1
cellular anatomical structure	1
coated vesicle	1
synaptic vesicle	1
exocytic vesicle membrane	1
trans-Golgi network	1
organelle membrane	1
specific granule	1
zymogen granule	1
endosome membrane	1
recycling endosome	1
cytoplasm	1
intracellular membrane-bounded organelle	1
vesicle membrane	1
cell junction	1

Protein interactions and networks

STRING

1102 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
SCAMP1	ITSN1	Q15811	773
SCAMP1	SYNRG	Q9UMZ2	766
SCAMP1	ITSN2	Q9NZM3	553
SCAMP1	ARF6	P26438	502
SCAMP1	EXOC5	O00471	479
SCAMP1	RAB9A	P51151	460
SCAMP1	STON2	Q8WXE9	445
SCAMP1	HOOK3	Q86VS8	430
SCAMP1	BAZ1A	Q9NRL2	429
SCAMP1	LRRC8B	Q6P9F7	429
SCAMP1	TBC1D15	Q8TC07	428
SCAMP1	KIF5B	P33176	422
SCAMP1	SLC44A1	Q8WWI5	420
SCAMP1	RAB3B	P20337	418
SCAMP1	HOOK1	Q9UJC3	415

IntAct

158 interactions, top by confidence:

A	B	Type	Score
CFTR	ESYT2	psi-mi:“MI:2364”(proximity)	0.710
CD27	TCAF2	psi-mi:“MI:0914”(association)	0.640
ENPP6	SCAMP1	psi-mi:“MI:0914”(association)	0.640
ABCD4	ABCD4	psi-mi:“MI:0914”(association)	0.640
LYPD3	SCAMP1	psi-mi:“MI:0914”(association)	0.640
SCAMP1	DNAJC13	psi-mi:“MI:0915”(physical association)	0.620
SCAMP1	DNAJC13	psi-mi:“MI:0914”(association)	0.620
TASOR2	SCAMP1	psi-mi:“MI:0915”(physical association)	0.560
ZMIZ2	SCAMP1	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1		psi-mi:“MI:0915”(physical association)	0.560
	SCAMP1	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	NDRG4	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	PCYT1A	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	MTERF3	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	THAP4	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	PBX3	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	SPG21	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	ARFIP2	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	ARFIP1	psi-mi:“MI:0915”(physical association)	0.560
SCAMP1	PTPN9	psi-mi:“MI:0915”(physical association)	0.560

BioGRID (286): FAM208B (Two-hybrid), ZMIZ2 (Two-hybrid), KRTAP13-1 (Two-hybrid), SCAMP1 (Affinity Capture-RNA), SCAMP1 (Affinity Capture-RNA), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Affinity Capture-MS), SCAMP1 (Proximity Label-MS)

ESM2 similar proteins: A5D7K7, B4DJY2, D3Z1U7, D3ZWZ9, O09117, O15126, O15127, O46521, O62646, O77735, O89104, P13164, P13498, P17971, P52650, P56603, P59995, Q05B54, Q0VBF8, Q16563, Q28CV2, Q2MHH0, Q5TYP8, Q5VSE6, Q5VXT5, Q61462, Q62737, Q63881, Q66IQ1, Q69YW2, Q6DFT4, Q6GQE1, Q8BGA2, Q8BLV3, Q8C838, Q8HYZ1, Q8IXB3, Q8K021, Q91499, Q95L73

Diamond homologs: O14828, O15126, O15127, O35609, O77735, P56603, Q17QF8, Q28F21, Q58DF6, Q58DR5, Q5R5Z8, Q5RCY9, Q6GM42, Q6GPA8, Q6P0C7, Q8K021, Q8TAC9, Q969E2, Q9ERN0, Q9ET20, Q9JKD3, Q9JKE3, Q9JKV5, Q9LR68, Q0JAI9, Q6Z8F5, Q9SXA5, Q9SKT3, Q9M5P2, Q9C6X2, Q9ZTX0, Q60EA5, A2YMP7, Q75IC7, Q7F613, Q8H5X5

SIGNOR signaling

1 interactions.

A	Effect	B	Mechanism
EGFR	“up-regulates activity”	SCAMP1	phosphorylation

Disease & clinical

Clinical variants and AI predictions

ClinVar

25 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	10
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2015 predictions. Top by Δscore:

Variant	Effect	Δscore
5:78360726:AAGGT:A	donor_loss	1.0000
5:78360730:T:A	donor_loss	1.0000
5:78388830:A:AG	acceptor_gain	1.0000
5:78388834:TAG:T	acceptor_loss	1.0000
5:78388835:A:AG	acceptor_gain	1.0000
5:78388835:A:G	acceptor_loss	1.0000
5:78388835:AG:A	acceptor_gain	1.0000
5:78388836:G:GT	acceptor_gain	1.0000
5:78388836:GG:G	acceptor_gain	1.0000
5:78388910:GAACA:G	donor_gain	1.0000
5:78388913:CA:C	donor_gain	1.0000
5:78388915:G:GG	donor_gain	1.0000
5:78415509:A:AG	acceptor_gain	1.0000
5:78415510:A:G	acceptor_gain	1.0000
5:78415515:CCTA:C	acceptor_loss	1.0000
5:78415516:CTA:C	acceptor_loss	1.0000
5:78415518:A:AG	acceptor_gain	1.0000
5:78415518:AG:A	acceptor_loss	1.0000
5:78415519:G:GT	acceptor_gain	1.0000
5:78415519:GC:G	acceptor_gain	1.0000
5:78415519:GCC:G	acceptor_gain	1.0000
5:78415519:GCCT:G	acceptor_gain	1.0000
5:78415519:GCCTC:G	acceptor_gain	1.0000
5:78415615:AAAG:A	donor_loss	1.0000
5:78415618:GGTT:G	donor_loss	1.0000
5:78415619:G:A	donor_loss	1.0000
5:78416536:TTTA:T	acceptor_loss	1.0000
5:78416538:TAG:T	acceptor_loss	1.0000
5:78416539:A:AG	acceptor_gain	1.0000
5:78416540:G:GG	acceptor_gain	1.0000

AlphaMissense

2245 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
5:78416587:T:C	L94P	1.000
5:78416598:G:C	A98P	1.000
5:78418789:T:A	W120R	1.000
5:78418789:T:C	W120R	1.000
5:78421932:T:A	W202R	1.000
5:78421932:T:C	W202R	1.000
5:78459249:T:A	W247R	1.000
5:78459249:T:C	W247R	1.000
5:78475520:G:C	R290P	1.000
5:78475547:C:A	A299D	1.000
5:78475559:T:C	F303S	1.000
5:78475589:T:A	V313D	1.000
5:78475600:G:C	A317P	1.000
5:78475601:C:A	A317D	1.000
5:78475613:C:A	A321D	1.000
5:78360696:T:C	F9L	0.999
5:78360697:T:G	F9C	0.999
5:78360698:T:A	F9L	0.999
5:78360698:T:G	F9L	0.999
5:78388897:T:C	F40L	0.999
5:78388898:T:G	F40C	0.999
5:78388899:C:A	F40L	0.999
5:78388899:C:G	F40L	0.999
5:78416575:G:C	R90P	0.999
5:78416578:A:C	Q91P	0.999
5:78416601:G:C	A99P	0.999
5:78416608:T:C	L101S	0.999
5:78416617:G:C	R104P	0.999
5:78418788:T:A	N119K	0.999
5:78418788:T:G	N119K	0.999

dbSNP variants (sampled 300 via entrez): RS1000034845 (5:78408667 C>G), RS1000062987 (5:78438087 A>G), RS1000076441 (5:78471750 A>G), RS1000083589 (5:78359737 G>C), RS1000098899 (5:78388358 T>C), RS1000131252 (5:78388138 C>T), RS1000135304 (5:78401222 T>C,G), RS1000176116 (5:78388443 C>G), RS1000183970 (5:78475334 A>G), RS1000245021 (5:78359640 C>G,T), RS1000249174 (5:78475927 G>A,T), RS1000293774 (5:78468623 T>C), RS1000300929 (5:78448992 C>T), RS1000319224 (5:78375614 T>C), RS1000329194 (5:78394828 G>A)

Disease associations

OMIM: gene MIM:606911 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

Study	Trait	p-value
GCST000461_21	Hippocampal atrophy	2.000000e-06
GCST003301_5	Triglycerides	7.000000e-08
GCST006412_23	Intraocular pressure	7.000000e-09
GCST90002400_689	Plateletcrit	2.000000e-12
GCST90002402_775	Platelet count	2.000000e-34

EFO canonical traits (5, from GWAS)

EFO ID	Trait name
EFO:0005039	hippocampal atrophy
EFO:0004530	triglyceride measurement
EFO:0004695	intraocular pressure measurement
EFO:0007985	platelet crit
EFO:0004309	platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

56 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
cobaltous chloride	affects cotreatment, increases expression	3
Phenylmercuric Acetate	affects cotreatment, decreases expression	2
Tetrachlorodibenzodioxin	affects expression, decreases expression	2
Tretinoin	decreases expression	2
Valproic Acid	increases expression	2
Cadmium Chloride	decreases reaction, increases abundance, increases palmitoylation, decreases expression	2
aristolochic acid I	decreases expression	1
GSK-J4	increases expression	1
FR900359	increases phosphorylation	1
dicrotophos	decreases expression	1
testosterone enanthate	affects expression	1
methylmercuric chloride	decreases expression	1
uranyl acetate	affects expression	1
pirinixic acid	affects binding, increases activity, increases expression	1
lead acetate	affects cotreatment, decreases expression	1
beta-lapachone	decreases expression	1
zinc protoporphyrin	affects cotreatment, decreases expression	1
sodium arsenite	decreases expression, increases abundance	1
2-bromopalmitate	increases palmitoylation, decreases reaction, increases abundance	1
lead chloride	affects cotreatment, increases expression	1
coumarin	decreases phosphorylation	1
cadmium sulfate	affects cotreatment, increases expression	1
beta-methylcholine	affects expression	1
tamibarotene	affects expression	1
di-n-butylphosphoric acid	affects expression	1
indolo(3,2-b)carbazole	decreases expression	1
CGP 52608	affects binding, increases reaction	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	affects cotreatment, decreases expression	1
dorsomorphin	affects cotreatment, decreases expression	1
Rosiglitazone	increases expression	1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_B2EM	Abcam HeLa SCAMP1 KO	Cancer cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.